Processing

Please wait...

Settings

Settings

Goto Application

1. RU0002756773 - COMPOSITIONS BASED ON CANNABIDIOL AND THEIR USE METHODS

Office
Russian Federation
Application Number 2018146644
Application Date 01.06.2017
Publication Number 0002756773
Publication Date 09.07.2020
Grant Number
Grant Date 05.10.2021
Publication Kind C2
IPC
A23L 5/00
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
5Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
D21H 25/00
DTEXTILES; PAPER
21PAPER-MAKING; PRODUCTION OF CELLULOSE
HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C, D21D84; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G97; PAPER NOT OTHERWISE PROVIDED FOR
25After-treatment of paper not provided for in groups D21H17/-D21H23/104
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 8/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
CPC
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61L 2202/25
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
2202Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
20Targets to be treated
25Rooms in buildings, passenger compartments
A61L 27/54
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
27Materials for ; grafts or; prostheses or for coating ; grafts or; prostheses
50Materials characterised by their function or physical properties ; , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
54Biologically active materials, e.g. therapeutic substances
A61L 29/085
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
29Materials for catheters, ; medical tubing, cannulae, or endoscopes; or for coating catheters
08Materials for coatings
085Macromolecular materials
A61L 29/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
29Materials for catheters, ; medical tubing, cannulae, or endoscopes; or for coating catheters
14Materials characterised by their function or physical properties ; , e.g. lubricating compositions
16Biologically active materials, e.g. therapeutic substances
A61L 31/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
31Materials for other surgical articles ; , e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
08Materials for coatings
10Macromolecular materials
Applicants ФАРМОТЕК СА (CH)
Inventors ЭШБАХ, Роден (CH)
AESCHBACH, Rodin (CH)
Priority Data 16172574 02.06.2016 EP
Title
(EN) COMPOSITIONS BASED ON CANNABIDIOL AND THEIR USE METHODS
(RU) КОМПОЗИЦИИ НА ОСНОВЕ КАННАБИДИОЛА И ПУТИ ИХ ПРИМЕНЕНИЯ
Abstract
(EN) FIELD: pharmaceutics. SUBSTANCE: proposed group of inventions relates to the pharmaceutical industry, namely, to the use of a composition for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria. The use of a CBD-based composition containing CBD in concentration from 1.9 mcg/ml to 200 mg/ml for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria is proposed, where the disease or disorder is selected from a group consisting of nosocomial infection, respiratory tract infections, skin and soft tissue infections, wound infections, dental and buccal infections, otorhinolaryngological infections, urinary and/or prostate tract infections, gastrointestinal infections, biliary tract infections, eye infections, bacteremia, sepsis, central nervous system infections and endocarditis. A method for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria is proposed, where the disease or disorder is selected from a group consisting of nosocomial infection, respiratory tract infections, skin and soft tissue infections, wound infections, dental and buccal infections, otorhinolaryngological infections, urinary and/or prostate tract infections, gastrointestinal infections, biliary tract infections, eye infections, bacteremia, sepsis, central nervous system infections and endocarditis, wherein the specified method includes the injection of therapeutically effective amount of the composition containing CBD in concentration from 1.9 mcg/ml to 200 mg/ml, to a subject who needs it. EFFECT: above-described use and method are effective for inhibiting the formation of biofilm and/or virulence of P. aeruginosa, for the prevention and/or treatment of a disease caused by P. aeruginosa bacteria. 9 cl, 2 dwg, 1 tbl, 3 ex
(RU) Предложенная группа изобретений относится к фармацевтической промышленности, а именно к применению композиции для предупреждения и/или лечения заболевания, вызванного бактериями P. aeruginosa. Применение композиции на основе CBD, содержащей CBD в концентрации от 1,9 мкг/мл до 200 мг/мл, для предупреждения и/или лечения заболевания, вызванного бактериями P. aeruginosa, где заболевание или нарушение выбрано из группы, состоящей из внутрибольничной инфекции, инфекций дыхательных путей, инфекций кожи и мягких тканей, раневых инфекций, зубных и буккальных инфекций, оториноларингологических инфекций, инфекций мочевыводящих и/или предстательных путей, желудочно-кишечных инфекций, инфекции желчевыводящих путей, глазных инфекций, бактериемии, сепсиса, инфекций центральной нервной системы и эндокардита. Способ предупреждения и/или лечения заболевания, вызванного бактериями P. aeruginosa, где заболевание или нарушение выбрано из группы, состоящей из внутрибольничной инфекции, инфекций дыхательных путей, инфекций кожи и мягких тканей, раневых инфекций, зубных и буккальных инфекций, оториноларингологических инфекций, инфекций мочевыводящих и/или предстательных путей, желудочно-кишечных инфекций, инфекции желчевыводящих путей, глазных инфекций, бактериемии, сепсиса, инфекций центральной нервной системы и эндокардита, причем указанный способ включает введение терапевтически эффективного количества композиции, содержащей CBD в концентрации от 1,9 мкг/мл до 200 мг/мл, нуждающемуся в этом субъекту. Вышеописанные применение и способ эффективны для ингибирования формирования биопленки и/или вирулентности P. aeruginosa, для предупреждения и/или лечения заболевания, вызванного бактериями P. aeruginosa. 2 н. и 7 з.п. ф-лы, 2 ил., 1 табл., 3 пр.
Related patent documents
CL2018-3425This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.